id | C00001789 |
---|---|
Name | Yohimbine |
CAS RN | 146-48-5 |
Standard InChI | InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1 |
Standard InChI (Main Layer) | InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3 |
Phytochemical cluster | No. 4 |
---|---|
KCF-S cluster | No. 229 |
By standard InChI | CHEMBL15245 |
---|---|
By standard InChI Main Layer | CHEMBL10347 CHEMBL15245 CHEMBL31410 CHEMBL196400 CHEMBL465600 CHEMBL1327758 CHEMBL1472740 CHEMBL1473950 CHEMBL1475803 CHEMBL1514351 CHEMBL1526082 CHEMBL1531132 CHEMBL1625779 CHEMBL2079555 |
By LinkDB | C09256 |
---|
By CAS RN | D015016 |
---|
class name | count |
---|---|
asterids | 7 |
family name | count |
---|---|
Rubiaceae | 4 |
Apocynaceae | 3 |
Hominidae | 2 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1514351 CHEMBL2079555 |
CHEMBL729201
(1)
CHEMBL729203
(1)
CHEMBL729204 (1) CHEMBL729205 (1) CHEMBL729206 (3) CHEMBL758056 (1) CHEMBL828928 (1) CHEMBL827154 (1) CHEMBL1614110 (11) CHEMBL1741321 (9) CHEMBL1909136 (2) |
1 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | CHEMBL15245 |
CHEMBL1613805
(1)
|
0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | CHEMBL31410 CHEMBL1531132 |
CHEMBL1738312
(2)
|
0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | CHEMBL15245 |
CHEMBL1794367
(1)
|
1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL1794499
(3)
|
2 / 0 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | CHEMBL15245 |
CHEMBL1738091
(1)
CHEMBL1738565
(1)
CHEMBL1909139 (2) |
0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | CHEMBL15245 |
CHEMBL1909131
(2)
|
0 / 3 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL15245 |
CHEMBL1909190
(2)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL15245 |
CHEMBL1909195
(2)
|
2 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | CHEMBL15245 |
CHEMBL881969
(1)
CHEMBL1909215
(2)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL15245 |
CHEMBL1909201
(2)
|
0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | CHEMBL15245 |
CHEMBL1909176
(2)
|
0 / 0 |
P04062 | Glucosylceramidase | Enzyme | CHEMBL1472740 |
CHEMBL1613818
(1)
|
6 / 4 |
P29466 | Caspase-1 | C14 | CHEMBL15245 |
CHEMBL1909193
(2)
|
0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL15245 |
CHEMBL1909198
(2)
|
0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | CHEMBL15245 |
CHEMBL1909199
(2)
|
0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | CHEMBL15245 |
CHEMBL1909197
(2)
|
2 / 2 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL15245 CHEMBL31410 CHEMBL1531132 |
CHEMBL1794585
(3)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL31410 CHEMBL1327758 |
CHEMBL1614544
(4)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL31410 CHEMBL1327758 |
CHEMBL1614281
(1)
CHEMBL1614361
(3)
|
3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL1472740 |
CHEMBL1613776
(1)
|
3 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | CHEMBL15245 |
CHEMBL1909123
(2)
|
1 / 2 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | CHEMBL15245 |
CHEMBL1909092
(2)
|
0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | CHEMBL15245 |
CHEMBL1909169
(2)
|
1 / 1 |
P25021 | Histamine H2 receptor | Histamine receptor | CHEMBL15245 |
CHEMBL1909157
(2)
|
0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | CHEMBL15245 |
CHEMBL1909156
(2)
|
0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | CHEMBL15245 |
CHEMBL1909143
(2)
|
1 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909174
(2)
|
0 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 CHEMBL196400 |
CHEMBL644360
(1)
CHEMBL644361
(1)
CHEMBL644362 (2) CHEMBL644363 (2) CHEMBL644364 (2) CHEMBL644527 (4) CHEMBL644528 (4) CHEMBL644529 (4) CHEMBL644530 (4) CHEMBL641047 (1) CHEMBL641385 (1) CHEMBL642214 (1) CHEMBL645606 (1) CHEMBL645613 (1) CHEMBL646110 (1) CHEMBL649186 (1) CHEMBL649187 (1) CHEMBL649188 (1) CHEMBL649189 (1) CHEMBL649190 (1) CHEMBL649191 (1) CHEMBL649192 (1) CHEMBL649193 (1) CHEMBL649194 (1) CHEMBL649195 (1) CHEMBL873171 (1) CHEMBL649196 (1) CHEMBL875438 (1) CHEMBL649197 (1) CHEMBL648623 (3) CHEMBL648085 (1) CHEMBL648086 (1) CHEMBL647414 (1) CHEMBL768015 (3) CHEMBL822824 (1) CHEMBL843759 (1) CHEMBL829301 (1) CHEMBL1909090 (2) |
0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | CHEMBL15245 |
CHEMBL1909093
(2)
|
0 / 0 |
P08183 | Multidrug resistance protein 1 | drug | CHEMBL15245 |
CHEMBL1908285
(1)
CHEMBL1908286
(1)
CHEMBL1908289 (1) CHEMBL1908291 (1) CHEMBL1908292 (1) |
1 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | CHEMBL15245 |
CHEMBL1909127
(2)
|
0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | CHEMBL15245 |
CHEMBL1909204
(2)
|
0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | CHEMBL15245 |
CHEMBL1909202
(2)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1514351 |
CHEMBL1614027
(2)
CHEMBL1741325
(9)
CHEMBL1909135 (2) |
0 / 1 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | CHEMBL15245 |
CHEMBL1909203
(2)
|
1 / 11 |
P11387 | DNA topoisomerase 1 | Isomerase | CHEMBL15245 CHEMBL465600 |
CHEMBL1003401
(3)
|
0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL1472740 |
CHEMBL1794311
(1)
|
2 / 3 |
P14416 | D(2) dopamine receptor | Dopamine receptor | CHEMBL15245 |
CHEMBL1909140
(2)
|
2 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | CHEMBL15245 |
CHEMBL1909130
(2)
|
0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | CHEMBL15245 |
CHEMBL1909120
(2)
|
0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | CHEMBL15245 |
CHEMBL1909181
(2)
|
0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | CHEMBL15245 |
CHEMBL1909164
(2)
|
0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | CHEMBL15245 |
CHEMBL1909214
(2)
|
0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | CHEMBL15245 |
CHEMBL1909175
(2)
|
0 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | CHEMBL15245 |
CHEMBL1909096
(2)
|
1 / 1 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | CHEMBL15245 |
CHEMBL1909118
(2)
|
0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | CHEMBL15245 |
CHEMBL1909166
(2)
|
1 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL31410 CHEMBL1472740 |
CHEMBL1614458
(2)
|
0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | CHEMBL31410 CHEMBL1531132 |
CHEMBL1794495
(2)
|
2 / 2 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | CHEMBL15245 |
CHEMBL1909133
(2)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL31410 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL10347 CHEMBL31410 |
CHEMBL1794486
(2)
|
0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | CHEMBL15245 |
CHEMBL1738606
(1)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL31410 |
CHEMBL2114780
(1)
|
0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | CHEMBL15245 |
CHEMBL1909158
(2)
|
0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 CHEMBL196400 |
CHEMBL644360
(1)
CHEMBL644361
(1)
CHEMBL644362 (2) CHEMBL644363 (2) CHEMBL644364 (2) CHEMBL644527 (4) CHEMBL644528 (4) CHEMBL644529 (4) CHEMBL644530 (4) CHEMBL647963 (1) CHEMBL647721 (3) CHEMBL647725 (1) CHEMBL641047 (1) CHEMBL641385 (1) CHEMBL642214 (1) CHEMBL645606 (1) CHEMBL645613 (1) CHEMBL646110 (1) CHEMBL649186 (1) CHEMBL649187 (1) CHEMBL649188 (1) CHEMBL649189 (1) CHEMBL649190 (1) CHEMBL649191 (1) CHEMBL649192 (1) CHEMBL649193 (1) CHEMBL649194 (1) CHEMBL649195 (1) CHEMBL873171 (1) CHEMBL649196 (1) CHEMBL875438 (1) CHEMBL649197 (1) CHEMBL648085 (1) CHEMBL648086 (1) CHEMBL647414 (1) CHEMBL768015 (3) CHEMBL822824 (1) CHEMBL843759 (1) CHEMBL839549 (1) CHEMBL972062 (1) CHEMBL1226896 (2) CHEMBL1227024 (1) CHEMBL1228582 (1) CHEMBL1228583 (1) CHEMBL1228584 (2) CHEMBL1909088 (2) |
0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | CHEMBL15245 |
CHEMBL1909142
(2)
|
0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | CHEMBL15245 |
CHEMBL1909101
(2)
|
0 / 0 |
P35348 | Alpha-1A adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL647014
(1)
CHEMBL648807
(1)
CHEMBL647810 (2) CHEMBL647813 (1) CHEMBL647045 (3) CHEMBL772607 (1) CHEMBL815329 (1) CHEMBL840159 (1) |
0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | CHEMBL15245 |
CHEMBL1909141
(2)
|
1 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | CHEMBL15245 |
CHEMBL1909180
(2)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL15245 |
CHEMBL1909146
(2)
|
0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | CHEMBL15245 |
CHEMBL850007
(1)
CHEMBL1909104
(2)
|
0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | CHEMBL15245 |
CHEMBL1909144
(2)
|
0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | CHEMBL15245 |
CHEMBL1909100
(2)
|
0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | CHEMBL15245 |
CHEMBL1909167
(2)
|
1 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | CHEMBL15245 |
CHEMBL1909129
(2)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL15245 |
CHEMBL1909194
(2)
|
0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | CHEMBL15245 |
CHEMBL1909110
(2)
|
1 / 0 |
P03956 | Interstitial collagenase | M10A | CHEMBL15245 |
CHEMBL1909196
(2)
|
0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | CHEMBL15245 |
CHEMBL1909119
(2)
|
0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | CHEMBL1531132 |
CHEMBL2114810
(1)
|
7 / 3 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL1472740 |
CHEMBL1794467
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL15245 |
CHEMBL1909150
(2)
|
0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909171
(2)
|
2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909170
(2)
|
0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | CHEMBL15245 |
CHEMBL1909122
(2)
|
0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | CHEMBL15245 |
CHEMBL1909109
(2)
|
2 / 0 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | CHEMBL15245 |
CHEMBL1909205
(2)
|
5 / 10 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909172
(2)
|
1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | CHEMBL15245 |
CHEMBL1909114
(2)
|
0 / 0 |
P30304 | M-phase inducer phosphatase 1 | Ser_Thr_Tyr | CHEMBL15245 |
CHEMBL2157130
(1)
|
0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | CHEMBL15245 |
CHEMBL1909125
(2)
|
0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | CHEMBL15245 |
CHEMBL1909126
(2)
|
3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | CHEMBL15245 |
CHEMBL1909108
(2)
|
0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | CHEMBL15245 |
CHEMBL1909124
(2)
|
1 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL15245 |
CHEMBL1909200
(2)
|
0 / 0 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | CHEMBL15245 |
CHEMBL1909207
(2)
|
2 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1514351 |
CHEMBL1741322
(9)
CHEMBL1909132
(2)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL1327758 CHEMBL1472740 CHEMBL1514351 |
CHEMBL1613910
(3)
|
3 / 3 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | CHEMBL15245 |
CHEMBL1909186
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL15245 |
CHEMBL1909145
(2)
|
1 / 1 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | CHEMBL15245 |
CHEMBL1909091
(2)
|
1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | CHEMBL15245 |
CHEMBL1909212
(2)
|
1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | CHEMBL15245 |
CHEMBL1909211
(2)
|
0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | CHEMBL15245 |
CHEMBL850007
(1)
CHEMBL1909105
(2)
|
0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | CHEMBL15245 |
CHEMBL1909182
(2)
|
0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | CHEMBL15245 |
CHEMBL1909173
(2)
|
0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | CHEMBL15245 |
CHEMBL1909113
(2)
|
0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | CHEMBL15245 |
CHEMBL1909187
(2)
|
0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | CHEMBL15245 |
CHEMBL1909168
(2)
|
0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | CHEMBL31410 |
CHEMBL1614274
(1)
CHEMBL1613823
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL1472740 CHEMBL1514351 |
CHEMBL1614240
(2)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1514351 |
CHEMBL1613777
(2)
CHEMBL1741323
(9)
CHEMBL1909134 (2) |
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL15245 CHEMBL31410 CHEMBL1327758 CHEMBL1472740 CHEMBL1473950 CHEMBL1514351 |
CHEMBL1614108
(4)
CHEMBL1613886
(4)
CHEMBL1741324 (9) CHEMBL1909138 (2) |
0 / 1 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | CHEMBL15245 |
CHEMBL1909137
(2)
|
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL31410 CHEMBL1531132 |
CHEMBL1794483
(2)
|
0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL31410 |
CHEMBL1737991
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL1327758 |
CHEMBL1614211
(1)
|
0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL1472740 CHEMBL1531132 |
CHEMBL1614250
(1)
CHEMBL1614421
(2)
|
4 / 3 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | CHEMBL10347 |
CHEMBL1061237
(1)
|
1 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | CHEMBL15245 |
CHEMBL806826
(1)
CHEMBL1909094
(2)
|
1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL646104
(3)
CHEMBL643573
(2)
CHEMBL647014 (1) CHEMBL648807 (1) CHEMBL647813 (1) CHEMBL772607 (1) CHEMBL1909087 (2) |
0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | CHEMBL15245 |
CHEMBL1909213
(2)
|
0 / 0 |
P35368 | Alpha-1B adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL647014
(1)
CHEMBL648807
(1)
CHEMBL647813 (1) CHEMBL648098 (2) CHEMBL649156 (3) CHEMBL651996 (1) CHEMBL651997 (1) CHEMBL772607 (1) |
0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | CHEMBL10347 CHEMBL15245 CHEMBL31410 CHEMBL196400 |
CHEMBL644360
(1)
CHEMBL644361
(1)
CHEMBL644362 (2) CHEMBL644363 (2) CHEMBL644364 (2) CHEMBL644527 (4) CHEMBL644528 (4) CHEMBL644529 (4) CHEMBL644530 (4) CHEMBL641047 (1) CHEMBL641385 (1) CHEMBL642214 (1) CHEMBL645606 (1) CHEMBL645613 (1) CHEMBL646110 (1) CHEMBL646117 (1) CHEMBL644759 (3) CHEMBL649186 (1) CHEMBL649187 (1) CHEMBL649188 (1) CHEMBL649189 (1) CHEMBL649190 (1) CHEMBL649191 (1) CHEMBL649192 (1) CHEMBL649193 (1) CHEMBL649194 (1) CHEMBL649195 (1) CHEMBL873171 (1) CHEMBL649196 (1) CHEMBL875438 (1) CHEMBL649197 (1) CHEMBL648085 (1) CHEMBL648086 (1) CHEMBL647414 (1) CHEMBL768015 (3) CHEMBL822824 (1) CHEMBL843759 (1) CHEMBL839550 (1) CHEMBL1909089 (2) |
0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | CHEMBL15245 |
CHEMBL1909116
(2)
|
1 / 1 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL15245 |
CHEMBL1909206
(2)
|
0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | CHEMBL15245 |
CHEMBL1909128
(2)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL1327758 |
CHEMBL1794536
(1)
|
0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | CHEMBL1327758 CHEMBL1472740 CHEMBL1531132 |
CHEMBL1613914
(4)
|
0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL15245 CHEMBL31410 |
CHEMBL1738442
(2)
|
0 / 0 |
O00255 | Menin | Unclassified protein | CHEMBL1327758 CHEMBL1472740 CHEMBL1514351 CHEMBL1531132 |
CHEMBL1614257
(2)
CHEMBL1614531
(5)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL1327758 CHEMBL1472740 CHEMBL1514351 CHEMBL1531132 |
CHEMBL1614257
(2)
CHEMBL1614531
(5)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL1327758 CHEMBL1475803 |
CHEMBL1613933
(2)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL1327758 CHEMBL1475803 |
CHEMBL1613933
(2)
|
1 / 6 |
Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL806152
(1)
CHEMBL806153
(3)
|
0 / 0 |
Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL806152
(1)
CHEMBL806153
(3)
|
2 / 2 |
P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | CHEMBL10347 CHEMBL15245 CHEMBL31410 |
CHEMBL806152
(1)
CHEMBL806153
(3)
|
3 / 2 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D015016 | 5243 |
ABCB1
ABC20 CD243 CLCS GP170 MDR1 P-GP PGY1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 (EC:3.6.3.44) | Yohimbine analog results in increased expression of ABCB1 mRNA |
increases expression
|
mRNA |
7476894
|
D015016 | 150 |
ADRA2A
ADRA2 ADRA2R ADRAR ALPHA2AAR ZNF32 |
adrenoceptor alpha 2A | Yohimbine inhibits the reaction [brimonidine promotes the reaction [Phenylephrine binds to and results in increased activity of ADRA2A protein]] |
affects binding
/ decreases reaction / increases activity / increases reaction |
protein |
10742289
|
D015016 | 150 |
ADRA2A
ADRA2 ADRA2R ADRAR ALPHA2AAR ZNF32 |
adrenoceptor alpha 2A | Yohimbine inhibits the reaction [Norepinephrine binds to and results in increased activity of ADRA2A protein] |
affects binding
/ decreases reaction / increases activity |
protein |
10742289
|
D015016 | 1082 |
CGB
CGB3 CGB5 CGB7 CGB8 hCGB |
chorionic gonadotropin, beta polypeptide | Yohimbine inhibits the reaction [amitraz inhibits the reaction [CGB protein results in increased abundance of Progesterone]] |
decreases reaction
/ increases abundance |
protein |
16085667
|
D015016 | 1082 |
CGB
CGB3 CGB5 CGB7 CGB8 hCGB |
chorionic gonadotropin, beta polypeptide | Yohimbine inhibits the reaction [amitraz results in decreased susceptibility to CGB protein] |
decreases reaction
/ decreases response to substance |
protein |
16085667
|
D015016 | 1565 |
CYP2D6
CPD6 CYP2D CYP2D7AP CYP2D7BP CYP2D7P2 CYP2D8P2 CYP2DL1 CYPIID6 P450-DB1 P450C2D P450DB1 |
cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) | CYP2D6 gene polymorphism affects the metabolism of Yohimbine |
affects metabolic processing
|
gene |
15289791
|
D015016 | 1576 |
CYP3A4
CP33 CP34 CYP3A CYP3A3 CYPIIIA3 CYPIIIA4 HLP NF-25 P450C3 P450PCN1 |
cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) | CYP3A4 gene polymorphism affects the metabolism of Yohimbine |
affects metabolic processing
|
gene |
15289791
|
D015016 | 5617 |
PRL
|
prolactin | Yohimbine results in increased expression of PRL protein |
increases expression
|
protein |
3153710
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#607208 | Dravet syndrome |
P35498
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
#615363 | Estrogen resistance; estrr |
P03372
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#612244 | Inflammatory bowel disease 13; ibd13 |
P08183
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
|
H00027 | Ovarian cancer |
P04626
(related)
|
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P35354 (related) |
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00036 | Osteosarcoma |
P08684
(marker)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00025 | Penile cancer |
P14780
(related)
P35354 (related) |
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
H00783 | Febrile seizures |
P35498
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00004 | Chronic myeloid leukemia (CML) |
Q01196
(related)
|
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D017109 | D015016 | Akathisia, Drug-Induced |
marker/mechanism
|
3372705
|
|
D000435 | D015016 | Alcoholic Intoxication |
marker/mechanism
|
7617798
|
|
D000647 | D015016 | Amnesia |
marker/mechanism
therapeutic |
15265636
20064624 |
|
D001008 | D015016 | Anxiety Disorders |
marker/mechanism
|
1506013
2867497 3372705 6505121 7617798 7950687 8340584 8744988 |
|
D001145 | D015016 | Arrhythmias, Cardiac |
therapeutic
|
2350327
|
|
D001342 | D015016 | Autonomic Nervous System Diseases |
therapeutic
|
8821553
|
|
D001714 | D015016 | Bipolar Disorder |
marker/mechanism
|
6091464
|
|
D001919 | D015016 | Bradycardia |
marker/mechanism
therapeutic |
978195
1527734 2157035 3039113 3505923 3720002 6117801 6121810 8623973 |
|
D001986 | D015016 | Bronchial Spasm |
marker/mechanism
|
7950687
|
|
D002303 | D015016 | Cardiac Output, Low |
therapeutic
|
7250202
|
|
D002375 | D015016 | Catalepsy |
therapeutic
|
9723970
12970091 15448976 19429072 |
|
D023341 | D015016 | Chills |
marker/mechanism
|
3153710
|
|
D019970 | D015016 | Cocaine-Related Disorders |
marker/mechanism
|
14872205
18824018 |
|
D006970 | D015016 | Disorders of Excessive Somnolence |
therapeutic
|
8318322
|
|
D003875 | D015016 | Drug Eruptions |
marker/mechanism
|
8470320
|
|
D056486 | D015016 | Drug-Induced Liver Injury |
therapeutic
|
2886651
|
|
D064420 | D015016 | Drug-Related Side Effects and Adverse Reactions |
marker/mechanism
|
4022276
|
|
D004409 | D015016 | Dyskinesia, Drug-Induced |
therapeutic
|
8106150
10495035 |
|
D007172 | D015016 | Erectile Dysfunction |
therapeutic
|
3352059
10337904 11896474 17874315 |
|
D005099 | D015016 | Exotropia |
marker/mechanism
|
3153710
|
|
D006930 | D015016 | Hyperalgesia |
marker/mechanism
therapeutic |
2128375
8987795 12727271 18799818 |
|
D006940 | D015016 | Hyperemia |
marker/mechanism
therapeutic |
2841874
7949234 |
|
D006943 | D015016 | Hyperglycemia |
therapeutic
|
17195055
|
|
D006948 | D015016 | Hyperkinesis |
therapeutic
|
2880435
20542064 |
|
D006966 | D015016 | Hyperprolactinemia |
marker/mechanism
|
1678730
|
|
D006973 | D015016 | Hypertension |
marker/mechanism
therapeutic |
1355091
2879903 3153710 3720002 6138461 7950687 8340584 8720421 10337904 19640235 |
|
D018476 | D015016 | Hypokinesia |
therapeutic
|
19429072
|
|
D007022 | D015016 | Hypotension |
marker/mechanism
therapeutic |
978195
2157035 2565755 2594901 2767128 2879903 3039113 3421530 3720846 6111465 6117801 6121810 6256140 7250202 8816361 |
|
D007024 | D015016 | Hypotension, Orthostatic |
marker/mechanism
therapeutic |
503823
2708559 2920499 3799828 3953875 7224460 10369619 |
|
D007859 | D015016 | Learning Disorders |
marker/mechanism
|
3153710
|
|
D001523 | D015016 | Mental Disorders |
marker/mechanism
|
2594901
19821221 |
|
D009069 | D015016 | Movement Disorders |
therapeutic
|
17306893
|
|
D009127 | D015016 | Muscle Rigidity |
therapeutic
|
3670563
|
|
D009203 | D015016 | Myocardial Infarction |
therapeutic
|
2350327
|
|
D017202 | D015016 | Myocardial Ischemia |
therapeutic
|
2429111
3768070 |
|
D015428 | D015016 | Myocardial Reperfusion Injury |
therapeutic
|
2350327
|
|
D009207 | D015016 | Myoclonus |
therapeutic
|
37558
|
|
D009325 | D015016 | Nausea |
marker/mechanism
|
3021082
|
|
D019954 | D015016 | Neurobehavioral Manifestations |
therapeutic
|
499336
|
|
D009765 | D015016 | Obesity |
therapeutic
|
2877928
|
|
D009293 | D015016 | Opioid-Related Disorders |
marker/mechanism
|
11955464
|
|
D016584 | D015016 | Panic Disorder |
marker/mechanism
|
3153710
8080348 10367182 10435213 14656453 |
|
D011141 | D015016 | Polyuria |
therapeutic
|
3505923
|
|
D012021 | D015016 | Reflex, Abnormal |
marker/mechanism
|
20394767
|
|
D051437 | D015016 | Renal Insufficiency |
marker/mechanism
|
8470320
|
|
D012640 | D015016 | Seizures |
marker/mechanism
therapeutic |
1326092
1527734 2566944 3040437 11685388 12180996 17728537 19640235 |
|
D012735 | D015016 | Sexual Dysfunction, Physiological |
marker/mechanism
|
3021082
|
|
D020018 | D015016 | Sexual Dysfunctions, Psychological |
therapeutic
|
1535072
1564046 2295589 2868483 12187545 |
|
D013313 | D015016 | Stress Disorders, Post-Traumatic |
marker/mechanism
|
10435213
|
|
D019966 | D015016 | Substance-Related Disorders |
marker/mechanism
|
3153710
|
|
D013375 | D015016 | Substance Withdrawal Syndrome |
marker/mechanism
|
11955464
|
|
D013610 | D015016 | Tachycardia |
marker/mechanism
|
2864424
3007177 6323192 8340584 19640235 |
|
D017180 | D015016 | Tachycardia, Ventricular |
marker/mechanism
therapeutic |
8720421
17852790 |
|
D014202 | D015016 | Tremor |
marker/mechanism
therapeutic |
3021082
3153710 3372705 3670563 |
|
D014474 | D015016 | Unconsciousness |
marker/mechanism
|
19640235
|
|
D014693 | D015016 | Ventricular Fibrillation |
therapeutic
|
2350327
8720421 |
|
D014839 | D015016 | Vomiting |
marker/mechanism
|
19640235
|
|
D014987 | D015016 | Xerostomia |
therapeutic
|
9272401
|